![](https://investorshub.advfn.com/uicon/40536.png?cb=1561902029)
Thursday, April 18, 2019 9:41:40 AM
My GUESS.... They are laser focused on doing what they are doing to get CaverStem FemCelz up and running with enough doctors to provide the services and then the gloves will come off.
IMO, much of what we crave, the corporate spokesman with a vision, the TV commercials, customer testimonials etc are all coming, but a blitz now would be too early. Customers don’t have a place to go. It’s like the Black Friday ad for a $50 80 inch 4K TV and everyone sleeps in front of the store all night to find they only had ONE.
CELZ is just getting off the ground. The PPS blows...... I know it, you know it, the company knows it.
The OTC is unpredictable. Just the buzz with all of this could have us at .10, or it can fall on deaf ears and put us where we are, sub penny. You know as well as I do that some shit azz stocks run into the quarters on almost nothing. Why not CELZ? I have no clue.
What I do feel strongly about is that they have been down this road before and know what they are doing. How the market reacts is largely out of their control, but when the proper infrastructure is done (trial paper, enough locations, enough trainers, hurdles jumped in Russia etc) the gloves will come off.
IMO, the science is there, the efficacy is there, the demand is there, and with the opioid crisis if full swing, anything that is a proven treatment that is NOT a drug is in the right spot at the right time.
Back in July I felt we would settle .04+ and keep moving, but we lost the momo when the offices did not open in time and CaverStem 2.0 needle was introduced... the OTC flippers and dilution killed the PPS, but many are now reloaded for the real run. I would call it a false start.
My current thoughts.... bail out and run for the hills if you think it’s a scam or mismanaged. Or add and these ridiculous prices and wait for the infrastructure to be in place and for the gloves to come off. CELZ has many adversaries, and they know it and are prepared for it. But hey, that is just me. To each their own.
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM